AI-native platforms are reshaping stem cell research, making regenerative medicine faster, cheaper, and more precise.
Cellular Intelligence Co-Founder & CEO Micha Breakstone joins Jon Fortt for a long-form conversation on decoding the language ...
Not long ago, solving the crystal structure of a protein required an entire PhD. Growing crystals, collecting X-ray diffraction data, and interpreting electron density maps often took years of ...
Researchers from more than 50 international institutions have launched Open Problems, a collaborative open-source platform to benchmark, improve, and run competitions for computational methods in ...
Deep inside a small, windowless room at the University of California, Berkeley, two microscopes are quietly capturing some of ...
Cellular Intelligence has secured global rights to Novo Nordisk's Parkinson's program, a clinical-stage allogeneic cell therapy for Parkinson's disease with FDA Fast Track Designation. Cellular ...
A company using artificial intelligence to develop bespoke cell cultures says that it has the potential to slash manufacturing times. Tolemy Bio claims that their machine learning algorithms can ...
Cell therapy developers looking to use predictive modeling in manufacturing should start small, according to industrial AI firm, Kosten Digital, which says taking the time to establish the right ...
Organoid intelligence sounds like sci-fi. But it’s here. See how it’s reshaping disease modelling, drug discovery, AI, robotics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results